论文部分内容阅读
目的探讨银杏达莫注射液治疗肺心病的临床疗效及应用价值。方法将2008年4月-2012年4月在我科接受治疗的62例肺心病患者随机分为观察组和对照组各31例,对照组给予止咳、平喘、抗感染、吸氧、改善心功能等常规治疗,观察组在此基础上加用银杏达莫注射液治疗,观察两组患者心功能改善情况,并进行疗效评定。结果观察组总有效率为83.87%,明显高于对照组的67.74%(P<0.05);观察组治疗后PaO2指标明显高于对照组,PaCO2指标明显低于对照组(P<0.05),两组患者治疗期间均未见任何与药物不良反应。结论银杏达莫注射液治疗肺心病安全、有效,值得临床推广应用。
Objective To investigate the clinical efficacy and clinical value of Ginkgo-damo Injection in the treatment of pulmonary heart disease. Methods From April 2008 to April 2012, 62 patients with pulmonary heart disease undergoing treatment in our department were randomly divided into observation group and control group, with 31 cases in each group. The control group was given antitussive, antiasthmatic, anti-infection, oxygen, Function and other conventional treatment, the observation group on this basis with the addition of Yin Xing Damo injection treatment to observe the improvement of cardiac function in both groups, and efficacy evaluation. Results The total effective rate in the observation group was 83.87%, which was significantly higher than that in the control group (67.74%, P <0.05). PaO2 index in the observation group was significantly higher than that in the control group (P <0.05) During the treatment of patients were not any adverse reactions with the drug. Conclusion Yinxingdamo injection for the treatment of pulmonary heart disease is safe and effective, worthy of clinical application.